RxDoctor Payments DataLook up a doctor →

TECVAYLI: payments to doctors

Payments that named TECVAYLI as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$6.7M
Providers
11,851
Transactions
44,593
Average per transaction
$151

The per-transaction average — $151 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,851 providers the average total is $568, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Johnson & Johnson$5,915,74387.9%
Janssen Scientific Affairs, LLC$296,1634.4%
Janssen Global Services, LLC$268,3594.0%
Janssen Research & Development, LLC$253,0063.8%
← All drugs & devices